Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing (EAC-UCI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01733940|
Recruitment Status : Unknown
Verified November 2012 by ANA ISABEL LÓPEZ FIGUERAS, Hospital Central de la Defensa Gómez Ulla.
Recruitment status was: Recruiting
First Posted : November 27, 2012
Last Update Posted : November 28, 2012
Introduction: The vascular catheter-related bacteremia (BRC) is a major health problem in intensive care units. The use of dressings containing chlorhexidine gluconate (CHG) can decrease the catheters colonization, closely related to infection thereof.
Objective: To determine the efficacy of the dressing "Tegaderm CHG" dressings versus "Tegaderm IV" dressings in reducing the risk of colonization of central intravascular catheters in the intensive care unit (ICU).
Methods: Randomized controlled trial with blinding professional who reviews the main outcome. The study included patients over 18 years, indicating the central intravascular catheter implantation in the ICU or in the operating room, prior informed consent. Excluding subjects with positive blood culture at the time of catheter implantation.
The estimated sample size is 398 patients, with a confidence level of 95% and a statistical power of 80%. The study protocol was approved by the ethics committee of the hospital.
Be made prospectively followed subjects from study entry until catheter removal collecting information on age, sex, APACHEII, antibiotic therapy, duration of catheter insertion site and removal, reason for withdrawal and microbiological information.
For statistical analysis, a model is adjusted multivariate logistic regression, determining the interaction of variables with the likelihood ratio test and confusion by switching between the crude and adjusted effect greater than 10%.
Results and conclusions: The recruitment has started in November 2012 and is scheduled for completion in March 2013. This study will determine whether these new dressings are effective in our environment.
|Condition or disease||Intervention/treatment||Phase|
|Intravascular Catheter Colonization||Device: Application of a dressing with clorhexidine gluconate in intravascular catheters. Device: Application of a dressing without clorhexidine gluconate||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||398 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing in the Reduction of Central Catheter Colonization in Patients of the Intensive Care Unit of the University "Gómez Ulla" Hospital.|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||June 2013|
Experimental: "Tegaderm CHG" Dressing
This arm is receiving a clorhexidine dressing for intravascular catheters.
|Device: Application of a dressing with clorhexidine gluconate in intravascular catheters.|
Active Comparator: "Tegaderm IV" dressing
Use of tegaderm iv dressings for intravascular catheters. Change each 7 days.
|Device: Application of a dressing without clorhexidine gluconate|
- Incidence of intravascular central catheter colonization. [ Time Frame: November 2012- March 2013 ]
- Adverse effects of CHG Tegaderm ® dressings. [ Time Frame: up to 4 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733940
|Contact: ana isabel lopez figueras, MD||0034911586958 ext firstname.lastname@example.org|
|Central Hospital of the Defense||Recruiting|
|Madrid, Spain, 28047|
|Contact: ana isabel lopez figueras email@example.com|
|Principal Investigator: Ana isabel López figueras|